Search

Jonathan Stuart Kaplan

Examiner (ID: 15168)

Most Active Art Unit
2836
Art Unit(s)
2107, 2104, 2836
Total Applications
226
Issued Applications
203
Pending Applications
10
Abandoned Applications
13

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7103835 [patent_doc_number] => 20050106561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B' [patent_app_type] => utility [patent_app_number] => 10/913910 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4219 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106561.pdf [firstpage_image] =>[orig_patent_app_number] => 10913910 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/913910
Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B Aug 5, 2004 Abandoned
Array ( [id] => 7116568 [patent_doc_number] => 20050069869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'SARS nucleic acids, proteins, antibodies, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/911838 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 29049 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20050069869.pdf [firstpage_image] =>[orig_patent_app_number] => 10911838 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/911838
SARS nucleic acids, proteins, antibodies, and uses thereof Aug 3, 2004 Issued
Array ( [id] => 7185226 [patent_doc_number] => 20050191747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Recombinant bovine immunodeficiency virus based gene transfer system' [patent_app_type] => utility [patent_app_number] => 10/910293 [patent_app_country] => US [patent_app_date] => 2004-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26893 [patent_no_of_claims] => 99 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191747.pdf [firstpage_image] =>[orig_patent_app_number] => 10910293 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/910293
Recombinant bovine immunodeficiency virus based gene transfer system Aug 3, 2004 Abandoned
Array ( [id] => 7033131 [patent_doc_number] => 20050031640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma' [patent_app_type] => utility [patent_app_number] => 10/910596 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5229 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20050031640.pdf [firstpage_image] =>[orig_patent_app_number] => 10910596 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/910596
Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma Aug 2, 2004 Issued
Array ( [id] => 281944 [patent_doc_number] => 07553944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Human virus causing respiratory tract infection and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/895064 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 9 [patent_no_of_words] => 19390 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553944.pdf [firstpage_image] =>[orig_patent_app_number] => 10895064 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/895064
Human virus causing respiratory tract infection and uses thereof Jul 20, 2004 Issued
Array ( [id] => 6938991 [patent_doc_number] => 20050112554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/888401 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21609 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112554.pdf [firstpage_image] =>[orig_patent_app_number] => 10888401 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/888401
Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof Jul 8, 2004 Issued
Array ( [id] => 6938581 [patent_doc_number] => 20050112144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Hepatitis A vaccines' [patent_app_type] => utility [patent_app_number] => 10/878094 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4135 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112144.pdf [firstpage_image] =>[orig_patent_app_number] => 10878094 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/878094
Hepatitis A vaccines Jun 27, 2004 Abandoned
Array ( [id] => 5045973 [patent_doc_number] => 20070264646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Hbv Particles Containing Hbv-Rna' [patent_app_type] => utility [patent_app_number] => 11/630254 [patent_app_country] => US [patent_app_date] => 2004-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3275 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264646.pdf [firstpage_image] =>[orig_patent_app_number] => 11630254 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/630254
Hbv Particles Containing Hbv-Rna Jun 21, 2004 Abandoned
Array ( [id] => 7275103 [patent_doc_number] => 20040234554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'HBV core antigen particles with multiple immunogenic components attached via peptide ligands' [patent_app_type] => new [patent_app_number] => 10/872550 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10079 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234554.pdf [firstpage_image] =>[orig_patent_app_number] => 10872550 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/872550
HBV core antigen particles with multiple immunogenic components attached via peptide ligands Jun 20, 2004 Issued
Array ( [id] => 7275091 [patent_doc_number] => 20040234542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications' [patent_app_type] => new [patent_app_number] => 10/476777 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 9145 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234542.pdf [firstpage_image] =>[orig_patent_app_number] => 10476777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/476777
Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications Jun 6, 2004 Abandoned
Array ( [id] => 7152638 [patent_doc_number] => 20050025788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Systemic delivery of non-viral vector expressing SARS viral genomic vaccine' [patent_app_type] => utility [patent_app_number] => 10/860119 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6080 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025788.pdf [firstpage_image] =>[orig_patent_app_number] => 10860119 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860119
Systemic delivery of non-viral vector expressing SARS viral genomic vaccine Jun 3, 2004 Abandoned
Array ( [id] => 7252581 [patent_doc_number] => 20040259243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Cells for detection of enteroviruses' [patent_app_type] => new [patent_app_number] => 10/861724 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18079 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259243.pdf [firstpage_image] =>[orig_patent_app_number] => 10861724 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/861724
Cells for detection of enteroviruses Jun 2, 2004 Issued
Array ( [id] => 7372152 [patent_doc_number] => 20040219171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'In ovo protection against infectious bronchitis' [patent_app_type] => new [patent_app_number] => 10/858277 [patent_app_country] => US [patent_app_date] => 2004-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4820 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219171.pdf [firstpage_image] =>[orig_patent_app_number] => 10858277 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/858277
Ovo immunization against infectious bronchitis May 31, 2004 Issued
Array ( [id] => 6931244 [patent_doc_number] => 20050282279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Expression vector encoding coronavirus-like particle' [patent_app_type] => utility [patent_app_number] => 10/855490 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5539 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282279.pdf [firstpage_image] =>[orig_patent_app_number] => 10855490 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855490
Expression vector encoding coronavirus-like particle May 27, 2004 Abandoned
Array ( [id] => 5732306 [patent_doc_number] => 20060257423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Intracutaneous injection combined vaccine included hevac and bcg for and preparation method' [patent_app_type] => utility [patent_app_number] => 10/559471 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3263 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257423.pdf [firstpage_image] =>[orig_patent_app_number] => 10559471 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559471
HBsAg-BCG combined vaccine for intracutaneous injection and preparation method thereof May 25, 2004 Issued
Array ( [id] => 698337 [patent_doc_number] => 07067249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Inhibition of hepatitis B virus (HBV) replication by RNA interference' [patent_app_type] => utility [patent_app_number] => 10/848736 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11978 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067249.pdf [firstpage_image] =>[orig_patent_app_number] => 10848736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848736
Inhibition of hepatitis B virus (HBV) replication by RNA interference May 18, 2004 Issued
Array ( [id] => 7426656 [patent_doc_number] => 20040265798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Methods and compositions related to high-titer pseudotyped retroviruses' [patent_app_type] => new [patent_app_number] => 10/845253 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23387 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265798.pdf [firstpage_image] =>[orig_patent_app_number] => 10845253 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/845253
Methods and compositions related to high-titer pseudotyped retroviruses May 12, 2004 Issued
Array ( [id] => 7689505 [patent_doc_number] => 20070105193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Severe acute respiratory syndrome DNA vaccine compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 10/843656 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 70388 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105193.pdf [firstpage_image] =>[orig_patent_app_number] => 10843656 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/843656
Severe acute respiratory syndrome DNA compositions and methods of use May 11, 2004 Issued
Array ( [id] => 5040654 [patent_doc_number] => 20070092936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Severe acute respiratory syndrome' [patent_app_type] => utility [patent_app_number] => 10/553844 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 2922 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092936.pdf [firstpage_image] =>[orig_patent_app_number] => 10553844 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553844
Severe acute respiratory syndrome May 9, 2004 Abandoned
Array ( [id] => 7421643 [patent_doc_number] => 20040229219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (SARS)' [patent_app_type] => new [patent_app_number] => 10/834666 [patent_app_country] => US [patent_app_date] => 2004-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 21416 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229219.pdf [firstpage_image] =>[orig_patent_app_number] => 10834666 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/834666
Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (SARS) Apr 28, 2004 Abandoned
Menu